A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Gene Therapy Cell Culture Media Market By Top Companies-Lonza - openPR.com
Gene Therapy Cell Culture Media Market By Top Companies-Lonza openPR.com
Lonza expands its GMP solutions for cell and gene therapy - SelectScience
Lonza expands its GMP solutions for cell and gene therapy SelectScience
Lonza Expands Cell and Gene Therapy Portfolio - Contract Pharma
Lonza Expands Cell and Gene Therapy Portfolio Contract Pharma
Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development - GEN - Genetic Engineering and Biotechnology News
Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development GEN - Genetic Engineering and Biotechnology News
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics - GEN - Genetic Engineering and Biotechnology News
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics GEN - Genetic Engineering and Biotechnology News
Top 10 Contract Development and Manufacturing Organizations 2025 - GEN - Genetic Engineering and Biotechnology News
Top 10 Contract Development and Manufacturing Organizations 2025 GEN - Genetic Engineering and Biotechnology News
Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility - Nutritional Outlook
Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility Nutritional Outlook
Lonza CHI receives NutraStrong Collagen Verified certification - nutritioninsight.com
Lonza CHI receives NutraStrong Collagen Verified certification nutritioninsight.com
SGS Nutrasource awards NutraStrong Collagen Verified certification to Lonza Capsules & Health Ingredients - Nutraceutical Business Review
SGS Nutrasource awards NutraStrong Collagen Verified certification to Lonza Capsules & Health Ingredients Nutraceutical Business Review
ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands - PR Newswire
ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands PR Newswire
A Swiss company bought Genentech's Vacaville plant — here's how it's going so far - San Francisco Business Times - The Business Journals
A Swiss company bought Genentech's Vacaville plant — here's how it's going so far - San Francisco Business Times The Business Journals
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge - BioSpectrum Asia
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge BioSpectrum Asia
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - GEN - Genetic Engineering and Biotechnology News
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention GEN - Genetic Engineering and Biotechnology News
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 - Contract Pharma
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 Contract Pharma
Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate - GEN - Genetic Engineering and Biotechnology News
Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate GEN - Genetic Engineering and Biotechnology News
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page